Treatment for Ewing's Sarcoma Jamaica Plain MA

Preliminary research suggests that the anticancer drug figitumumab might be an effective treatment for Ewing's sarcoma, a cancer that affects the areas in and near the bone, mainly in teenage boys.

Therese M Mulvey, MD
(617) 479-3550
10 Willard St
Quincy, MA
Business
Commonwealth Physicians Services Inc
Specialties
Oncology

Data Provided by:
Margaret J Lawler, MD
(617) 983-7777
1153 Centre St
Jamaica Plain, MA
Gender
Female
Education
Medical School: Mc Master Univ, Sch Of Med, Hamilton, Ont, Canada
Graduation Year: 1984
Hospital
Hospital: Faulkner Hosp, Boston, Ma
Group Practice: Faulkner Breast Ctr

Data Provided by:
Faina Nakhlis
(617) 983-7777
1153 Centre St
Boston, MA
Specialty
Surgical Oncology

Data Provided by:
Margaret Mary Duggan
(617) 983-7777
1153 Centre St
Boston, MA
Specialty
General Surgery, Surgical Oncology

Data Provided by:
Margaret J Lawler
(617) 983-7777
1153 Centre St
Boston, MA
Specialty
Surgical Oncology

Data Provided by:
Ante Sven Lundberg
(617) 232-9500
150 S Huntington Ave
Boston, MA
Specialty
Medical Oncology

Data Provided by:
Stephen Arthur Landaw, MD
781-235-3065 x221
241 Perkins St Unit C105
Jamaica Plain, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Medical School: George Washington Univ Sch Of Med & Hlth Sci, Washington Dc 20037
Graduation Year: 1959

Data Provided by:
Geoffrey K Sherwoo, MR
(617) 983-7160
1153 Centre St
Boston, MA
Specialties
Oncology (Cancer)
Gender
Male
Education
Graduation Year: 2007

Data Provided by:
Sreela Ghoshroy, MBBS
617-232-9500 x5544
150 S Huntington Ave
Jamaica Plain, MA
Specialties
Internal Medicine, Hematology-Oncology
Gender
Male
Education
Medical School: Univ Of Calcutta, Med Coll, Calcutta, We
Graduation Year: 1982

Data Provided by:
Mary Therese Brophy
(617) 232-9500
150 S Huntington Ave
Boston, MA
Specialty
Hematology / Oncology

Data Provided by:
Data Provided by:

Treatment for Ewing's Sarcoma

Provided By:

WEDNESDAY, Dec. 23 (HealthDay News) -- Preliminary research suggests that the anticancer drug figitumumab might be an effective treatment for Ewing's sarcoma, a cancer that affects the areas in and near the bone, mainly in teenage boys.

The drug must undergo two more phases of testing, however, according to a report published in the Dec. 23 online edition of The Lancet Oncology.

In the first phase of research, scientists looked at 29 patients with advanced sarcomas who received the drug between 2006 and 2008. The researchers wanted to assess its safety and ability to be tolerated.

Patients did experience some side effects, such as deep venous thrombosis, back pain and vomiting. Some of the patients appeared to respond well to the drug, the study authors noted.

"Figitumumab is well-tolerated and has antitumor activity in Ewing's sarcoma, warranting further investigation in this disease," the researchers wrote. "Our results show that figitumumab can be safe for both adult and pediatric sarcoma patients, and has single-agent antitumor activity in different sarcoma subtypes, including Ewing's sarcoma."

In a commentary accompanying the study, doctors wrote that "five-drug chemotherapy is routine in the treatment of Ewing's sarcoma, therefore improvement in outcome for these patients will likely require demonstration of the feasibility of combining the antibody with standard chemotherapy."

More information

The U.S. National Library of Medicine has more on Ewing's sarcoma.

SOURCE: The Lancet Oncology, news release, Dec. 23, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com